Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001493152-25-004472
Filing Date
2025-01-31
Accepted
2025-01-31 17:00:49
Documents
85

Document Format Files

Seq Description Document Type Size
1 form424b1.htm   iXBRL 424B1 3602975
2 form424b1_001.jpg GRAPHIC 6933
  Complete submission text file 0001493152-25-004472.txt   12534877

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vvos-20240930.xsd EX-101.SCH 60000
4 XBRL CALCULATION FILE vvos-20240930_cal.xml EX-101.CAL 80129
5 XBRL DEFINITION FILE vvos-20240930_def.xml EX-101.DEF 270224
6 XBRL LABEL FILE vvos-20240930_lab.xml EX-101.LAB 444930
7 XBRL PRESENTATION FILE vvos-20240930_pre.xml EX-101.PRE 398202
87 EXTRACTED XBRL INSTANCE DOCUMENT form424b1_htm.xml XML 2392973
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-284399 | Film No.: 25579240
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)